Go Pro
→ Elon Musk’s One Stock Retirement Plan (From Brownstone Research) (Ad)tc pixel Free BFRG Stock Alerts

Bullfrog AI (BFRG) Competitors

Bullfrog AI logo
$0.49 +0.03 (+6.30%)
Closing price 09/21/2026 04:00 PM Eastern
Extended Trading
$0.50 +0.01 (+1.42%)
As of 07:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BFRG vs. BNGO, VIVS, ISPC, TBIO, and BFRGW

Should you buy Bullfrog AI stock or one of its competitors? Bullfrog AI's main competitors and comparable companies include Bionano Genomics (BNGO), VivoSim Labs (VIVS), iSpecimen (ISPC), Telesis Bio (TBIO), and Bullfrog AI (BFRGW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Bullfrog AI compare to Bionano Genomics?

Bionano Genomics (NASDAQ:BNGO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

In the previous week, Bullfrog AI had 1 more articles in the media than Bionano Genomics. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Bionano Genomics. Bullfrog AI's average media sentiment score of 1.71 beat Bionano Genomics' score of 0.23 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company Overall Sentiment
Bionano Genomics Neutral
Bullfrog AI Very Positive

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -106.58%. Bionano Genomics' return on equity of -78.78% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Bionano Genomics-106.58% -78.78% -48.54%
Bullfrog AI N/A -150.36%-127.98%

Bullfrog AI has lower revenue, but higher earnings than Bionano Genomics. Bullfrog AI is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bionano Genomics$28.51M0.76-$26.40M-$3.02N/A
Bullfrog AI$120K76.17-$6.50M-$0.46N/A

Bionano Genomics currently has a consensus price target of $6.00, indicating a potential upside of 227.87%. Given Bionano Genomics' stronger consensus rating and higher probable upside, research analysts clearly believe Bionano Genomics is more favorable than Bullfrog AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bionano Genomics
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Bullfrog AI
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Bionano Genomics has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.71, suggesting that its stock price is 371% less volatile than the broader market.

11.4% of Bionano Genomics shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 0.7% of Bionano Genomics shares are held by company insiders. Comparatively, 14.7% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Bionano Genomics beats Bullfrog AI on 9 of the 16 factors compared between the two stocks.

How does Bullfrog AI compare to VivoSim Labs?

VivoSim Labs (NASDAQ:VIVS) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

8.2% of VivoSim Labs shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 1.0% of VivoSim Labs shares are held by insiders. Comparatively, 14.7% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, VivoSim Labs had 3 more articles in the media than Bullfrog AI. MarketBeat recorded 4 mentions for VivoSim Labs and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.71 beat VivoSim Labs' score of 0.23 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
VivoSim Labs
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bullfrog AI
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VivoSim Labs
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Bullfrog AI
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
VivoSim Labs-11,016.07% -612.23% -177.02%
Bullfrog AI N/A -150.36%-127.98%

Bullfrog AI has lower revenue, but higher earnings than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VivoSim Labs$130K31.69-$13.84M-$4.47N/A
Bullfrog AI$120K76.17-$6.50M-$0.46N/A

VivoSim Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.71, suggesting that its stock price is 371% less volatile than the broader market.

Summary

Bullfrog AI beats VivoSim Labs on 9 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to iSpecimen?

Bullfrog AI (NASDAQ:BFRG) and iSpecimen (NASDAQ:ISPC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

In the previous week, Bullfrog AI had 1 more articles in the media than iSpecimen. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for iSpecimen. Bullfrog AI's average media sentiment score of 1.71 beat iSpecimen's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the media.

Company Overall Sentiment
Bullfrog AI Very Positive
iSpecimen Neutral

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -2,445.40%. Bullfrog AI's return on equity of -150.36% beat iSpecimen's return on equity.

Company Net Margins Return on Equity Return on Assets
Bullfrog AIN/A -150.36% -127.98%
iSpecimen -2,445.40%-524.39%-140.42%

Bullfrog AI has higher earnings, but lower revenue than iSpecimen. Bullfrog AI is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bullfrog AI$120K76.17-$6.50M-$0.46N/A
iSpecimen$1.93M1.72-$10.49M-$56.44N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
iSpecimen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by insiders. Comparatively, 12.2% of iSpecimen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Bullfrog AI has a beta of -2.71, indicating that its share price is 371% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.62, indicating that its share price is 62% more volatile than the broader market.

Summary

Bullfrog AI beats iSpecimen on 10 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to Telesis Bio?

Telesis Bio (NASDAQ:TBIO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Bullfrog AI had 1 more articles in the media than Telesis Bio. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Telesis Bio. Bullfrog AI's average media sentiment score of 1.71 beat Telesis Bio's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company Overall Sentiment
Telesis Bio Neutral
Bullfrog AI Very Positive

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
Bullfrog AI N/A -150.36%-127.98%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Telesis Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bullfrog AI
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Bullfrog AI has lower revenue, but higher earnings than Telesis Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A
Bullfrog AI$120K76.17-$6.50M-$0.46N/A

Telesis Bio has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.71, meaning that its stock price is 371% less volatile than the broader market.

37.6% of Telesis Bio shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by insiders. Comparatively, 14.7% of Bullfrog AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Telesis Bio and Bullfrog AI tied by winning 7 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to Bullfrog AI?

Bullfrog AI (NASDAQ:BFRGW) and Bullfrog AI (NASDAQ:BFRG) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Bullfrog AI has higher revenue and earnings than Bullfrog AI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bullfrog AI$298.80KN/AN/AN/AN/A
Bullfrog AI$120K76.17-$6.50M-$0.46N/A

1.0% of Bullfrog AI shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bullfrog AI
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Bullfrog AI had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.71 beat Bullfrog AI's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company Overall Sentiment
Bullfrog AI Neutral
Bullfrog AI Very Positive

Bullfrog AI's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Bullfrog AIN/A N/A N/A
Bullfrog AI N/A -150.36%-127.98%

Summary

Bullfrog AI beats Bullfrog AI on 5 of the 8 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRG vs. The Competition

Export
MetricBullfrog AILife Sciences Tools & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$8.60M$10.40B$7.25B$12.97B
Dividend YieldN/A1.46%2.53%12.80%
P/E Ratio-1.0773.72274.8125.77
Price / Sales76.17108.30696.06115.18
Price / CashN/A27.4728.0434.72
Price / Book2.595.7010.596.36
Net Income-$6.50M$56.67B$3.49B$358.17M
7 Day Performance9.97%3.73%0.78%1.58%
1 Month Performance-15.41%0.40%-2.82%-2.98%
1 Year Performance-66.69%28.13%16.67%5.63%

Bullfrog AI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRG
Bullfrog AI
1.1959 of 5 stars		$0.49
+6.3%		N/A-62.7%$8.60M$120KN/A17
BNGO
Bionano Genomics
2.2811 of 5 stars		$1.53
-2.2%		$6.00
+293.4%		+2.2%$17.96M$28.51MN/A300
VIVS
VivoSim Labs
0.7857 of 5 stars		$0.26
-3.5%		N/A-94.0%$4.35M$130KN/A20
ISPC
iSpecimen
0.2839 of 5 stars		$1.38
+3.8%		N/A-97.7%$3.48M$1.93MN/A60
TBIO
Telesis Bio
N/A$0.00
flat		N/A+0.0%$2K$225.09MN/A200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners
10% yields… from a gold security?
Most stocks yield under 2%. Even gold stocks average less than 1%. One gold security, backed by one of the wor...
Golden Portfolio | Sponsoredtc pixel
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
A councilman backed AI — then 13 bullets hit his front door
Thirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...
Stansberry Research | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
The next convergence is here
In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel